Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
James Sidoti is an analyst at Sidoti & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/07/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/29/2024 | SRDX | Buy Now | Surmodics | $28.50 | 50.88% | James Sidoti65% | → $43 | Downgrade | Buy → Neutral | Get Alert |
| 11/07/2022 | STAA | Buy Now | Staar Surgical | $16.14 | — | James Sidoti65% | — | Upgrade | Neutral → Buy | Get Alert |
| 08/12/2022 | CODX | Buy Now | Co-Diagnostics | $0.30 | 1566.67% | James Sidoti65% | → $5 | Downgrade | Buy → Neutral | Get Alert |
| 08/31/2020 | STAA | Buy Now | Staar Surgical | $16.14 | 259.36% | James Sidoti65% | → $58 | Upgrade | Neutral → Buy | Get Alert |
| 04/08/2020 | LMAT | Buy Now | LeMaitre Vascular | $79.39 | -57.17% | James Sidoti65% | $38 → $34 | Maintains | Buy | Get Alert |
| 03/27/2020 | HSKA | Buy Now | Heska | — | — | James Sidoti65% | $77 → $59 | Maintains | Neutral | Get Alert |
| 03/16/2020 | LMAT | Buy Now | LeMaitre Vascular | $79.39 | -52.14% | James Sidoti65% | → $38 | Upgrade | Neutral → Buy | Get Alert |
| 01/21/2020 | ANIK | Buy Now | Anika Therapeutics | $13.92 | 338.22% | James Sidoti65% | → $61 | Upgrade | Neutral → Buy | Get Alert |
| 01/15/2020 | HSKA | Buy Now | Heska | — | — | James Sidoti65% | $72 → $77 | Maintains | Neutral | Get Alert |
| 02/22/2019 | ANIK | Buy Now | Anika Therapeutics | $13.92 | 194.54% | James Sidoti65% | $56 → $41 | Downgrade | Buy → Neutral | Get Alert |
| 07/01/2016 | HSKA | Buy Now | Heska | — | — | James Sidoti65% | — | Initiates | → Buy | Get Alert |
